US SEC Filings Daily Market Digest — February 09, 2026

10-02-2026

Teradata Corp /DE/ filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006830), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This constitutes a standard voluntary disclosure of financial results typical for earnings announcements. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.

10-02-2026

Cambridge Acquisition Corp. filed an 8-K on 2026-02-10 disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, financial terms, parties involved, deal structure, or performance comparisons are explicitly stated. This filing indicates a merger/acquisition event but lacks details for comprehensive assessment.

10-02-2026

CVS Health Corp filed an 8-K on February 10, 2026 (AccNo: 0000064803-26-000009), reporting under Item 2.02 Results of Operations and Financial Condition, accompanied by Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantitative metrics available for analysis.

10-02-2026

Republic Airways Holdings Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043297), reporting under Item 3.02 for unregistered sales of equity securities and Item 8.01 for other events. This is a multi-item filing with no quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons disclosed. No positive or negative metrics, guidance changes, or scheduled events were mentioned.

10-02-2026

Quest Diagnostics Inc. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details. This is a multi-item filing typical for earnings releases, but lacks detailed performance data for analysis.

10-02-2026

Middlefield Banc Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001437749-26-003578), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific quantitative financial metrics, period-over-period comparisons, revenue, earnings, balance sheet changes, guidance, or other numerical data are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional performance indicators available.

10-02-2026

Williams Companies, Inc. filed an 8-K on 2026-02-10 disclosing Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item filing reporting financial results, but specific revenue, earnings, margins, comparisons, or guidance metrics are NOT_DISCLOSED. No positive or negative performance indicators, segment details, or balance sheet changes are provided in the filing description.

• ·AccNo: 0000107263-26-000003
• ·File size: 1 MB
• ·Sector: not specified

10-02-2026

10-02-2026

Hinge Health, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006826), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue figures, earnings, period-over-period comparisons, guidance, or other quantitative details are disclosed in the provided filing information. This is a multi-item filing likely related to financial results announcement.

10-02-2026

Gilead Sciences, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0000882095-26-000003, Size: 967 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing for a standard earnings release disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

10-02-2026

Zimmer Biomet Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043620), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing related to financial results, but specific revenue, earnings, guidance, or period-over-period metrics are NOT_DISCLOSED in the provided information. No positive, negative, or flat performance indicators are available.

10-02-2026

Axalta Coating Systems Ltd. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific financial metrics, quantitative data, period-over-period comparisons, guidance, or other details were provided in the filing summary.

10-02-2026

WESCO INTERNATIONAL INC filed an 8-K on February 10, 2026 (AccNo: 0000929008-26-000005), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, timing, or any compensatory arrangements are NOT_DISCLOSED. No quantitative data, performance metrics, scheduled events, or governance impacts are mentioned.

10-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary.

10-02-2026

DuPont de Nemours, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001666700-26-000007), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, likely an earnings release. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are mentioned in the provided filing details.

10-02-2026

Destiny Media Technologies Inc. filed an 8-K on 2026-02-10 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details on positions affected, individuals involved, reasons for change, or compensation amounts are disclosed.

10-02-2026

Ares Commercial Real Estate Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006634), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results, likely quarterly or annual earnings. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information.

10-02-2026

Harvard Bioscience Inc filed an 8-K on February 10, 2026 (AccNo: 0001171843-26-000721), disclosing results of operations and financial condition under Item 2.02 along with financial statements and exhibits under Item 9.01. No revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are explicitly stated in the filing description. This is a standard multi-item earnings-related disclosure with no directional performance indicators provided.

10-02-2026

REGENXBIO Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043342), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This is a multi-item filing with no details on timing relative to events or materiality.

10-02-2026

News Corp filed an 8-K on February 10, 2026 (AccNo: 0001564708-26-000031, Size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of any financial statements/exhibits are disclosed. This is a multi-item filing with no quantitative metrics, transaction details, or directional information provided.

10-02-2026

FG Nexus Inc. filed an 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific transaction details, financial metrics, or quantitative data provided in the filing metadata. No positive or negative performance indicators are disclosed.

10-02-2026

Calidi Biotherapeutics, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or directional information are disclosed in the provided filing summary. This appears to be a voluntary informational filing with attached exhibits, such as a press release or presentation.

10-02-2026

Silvaco Group, Inc. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the financial statements and exhibits are disclosed in the filing summary. No quantitative metrics, transactions, or scheduled events are mentioned.

10-02-2026

Virtuix Holdings Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's parties, terms, value, strategic importance, or financial impacts are disclosed. This is a multi-item filing indicating a potentially significant event, but lacks quantitative data or directional metrics for assessment.

10-02-2026

ScanTech AI Systems Inc. filed an 8-K on 2026-02-10 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing, which is a material negative event. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, dollar values, or period-over-period comparisons are disclosed.

10-02-2026

urban-gro, Inc. filed a Form 8-K on February 10, 2026, disclosing under Item 1.01 its entry into a Material Definitive Agreement. Item 9.01 lists Financial Statements and Exhibits. No specific details on the agreement, transaction value, financial impacts, or other metrics are provided in the filing summary.

10-02-2026

Webstar Technology Group Inc. filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement's nature, parties, dollar value, financial impacts, or strategic rationale are disclosed in the provided filing summary. This represents a multi-item mandatory disclosure of a material event.

10-02-2026

ZipRecruiter, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001617553-26-000004, Size: 204 KB), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment/resignation status, reasons, individuals involved, or any quantitative metrics are disclosed.

10-02-2026

Duke Energy Corporation filed a Form 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other performance details are provided in the filing description.

10-02-2026

Consensus Cloud Solutions, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or appointment under Item 5.02, with financial statements and exhibits under Item 9.01. Specific details on the affected position, whether it is an appointment or resignation, reasons for the change, and any financial metrics are NOT_DISCLOSED. No quantitative data, named executives, or scheduled events are provided in the filing summary.

10-02-2026

Lottery.com Inc. filed an 8-K on February 10, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, likely related to a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific vote outcomes, financial metrics, or other quantitative details are provided in the filing summary.

10-02-2026

Southern Missouri Bancorp, Inc. filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or operational details are disclosed in the filing summary provided. This appears to be a voluntary informational filing with attached exhibits, but content details are NOT_DISCLOSED.

10-02-2026

Synchrony Financial filed a Form 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary disclosure intended to release material nonpublic information, with exhibits likely attached (filing size 292 KB). No specific financial metrics, transactions, positive or negative changes, or other quantitative details are disclosed in the provided filing summary.

10-02-2026

M2i Global, Inc. filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely providing voluntary disclosure of material information with attached exhibits, such as a press release or presentation. No specific financial metrics, transactions, events, or quantitative data are disclosed in the filing summary.

• ·Accession Number: 0001493152-26-005830
• ·Filing size: 9 MB

10-02-2026

10-02-2026

Oscar Health, Inc. filed a Form 8-K on February 10, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing covering a material agreement, financial results, and new financial obligations, but specific details, metrics, or impacts are NOT_DISCLOSED. No quantitative financial data, period-over-period comparisons, or directional performance indicators (positive, negative, or flat) are provided.

10-02-2026

Aramark filed an 8-K on February 10, 2026 (AccNo: 0001584509-26-000037, Size: 919 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, guidance, or comparisons are mentioned.

10-02-2026

HASBRO, INC. filed an 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or period-over-period metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure without detailed quantitative data.

10-02-2026

LiveWire Group, Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators are mentioned.

10-02-2026

Harley-Davidson, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 and officer changes including departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements under Item 5.02. Item 9.01 references financial statements and exhibits. Specific details on the officer position, appointment or resignation reason, financial metrics, or performance comparisons are NOT_DISCLOSED.

10-02-2026

European Wax Center, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the agreement, events, or exhibits provided in the summary. No financial metrics, positive or negative changes, or quantitative impacts are disclosed.

10-02-2026

Blackbaud Inc filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, comparisons, or other quantitative metrics are disclosed in the provided filing information.

10-02-2026

Incyte Corp filed an 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), indicating a standard disclosure of financial results. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing details. This multi-item filing appears informational without detailed performance data.

10-02-2026

Xylem Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were disclosed in the provided filing details. This appears to be a standard earnings announcement filing with no quantified metrics available.

10-02-2026

Target Corp filed an 8-K on February 10, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for the change, or timing are provided in the filing summary. No quantitative metrics, financial impacts, or further governance implications are disclosed.

10-02-2026

Forgent Power Solutions, Inc. filed a multi-item Form 8-K on February 10, 2026, reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), and material modifications to rights of security holders (Item 3.03), alongside changes in directors or officers and compensatory arrangements (Item 5.02) and amendments to articles of incorporation or bylaws (Item 5.03). While the material agreement may represent strategic advancement, the equity sales and rights modifications raise concerns over potential dilution and altered shareholder protections. No quantitative transaction values, financial impacts, or performance metrics are disclosed.

10-02-2026

Trimble Inc. filed an 8-K on February 10, 2026 (AccNo: 0000864749-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.

• ·Filing size: 663 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

10-02-2026

Entegris Inc filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons were disclosed in the provided filing details. This represents a standard voluntary disclosure of financial results without quantified metrics.

10-02-2026

Marriott International Inc. filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, segment details, or outlook revisions are mentioned.

10-02-2026

Vestis Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006644, Size: 4 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, guidance, or period-over-period metrics are mentioned in the provided filing details. No positive or negative performance indicators are available.

10-02-2026

Bread Financial Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001101215-26-000010, size: 361 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details regarding the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided in the filing summary. Content of the disclosure is NOT_DISCLOSED.

10-02-2026

S&P Global Inc. filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), indicating a financial results announcement likely related to quarterly or annual earnings. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing metadata. This is a standard multi-item 8-K for earnings release with attached exhibits.

10-02-2026

Masco Corp /DE/ filed an 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics are disclosed in the filing description. This is an informational earnings-related disclosure without detailed performance data.

10-02-2026

ProPetro Holding Corp. filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided in the filing summary.

• ·Accession Number: 0001104659-26-012332
• ·File Size: 245 KB
• ·Sector: NOT_DISCLOSED

10-02-2026

Coca-Cola Co filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard voluntary earnings disclosure with attached exhibits.

10-02-2026

Fiserv Inc filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are mentioned in the filing details provided. All quantitative data such as transaction values, percentages, or period-over-period comparisons are NOT_DISCLOSED.

10-02-2026

Datadog, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001628280-26-006645, Size: 589 KB), under Item 2.02 to disclose its results of operations and financial condition as part of a financial results event. No specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are mentioned in the provided filing information. Sector details are not specified.

10-02-2026

Phio Pharmaceuticals Corp. filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

10-02-2026

The company filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012343), disclosing multiple events including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and financial statements and exhibits (Item 9.01). No quantitative data, transaction details, financial impacts, or specific descriptions of the events are provided in the filing summary. This multi-item filing indicates significant developments but lacks specifics for impact assessment.

10-02-2026

Soluna Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001493152-26-005888, size: 277 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the disclosed information, transactions, financial metrics, or events provided. No quantitative data or performance metrics are mentioned.

10-02-2026

Saia Inc filed an 8-K on 2026-02-10 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the filing summary provided. This appears to be a standard earnings-related disclosure without quantified metrics available.

10-02-2026

XPLR Infrastructure, LP filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, financial metrics, period-over-period comparisons, or performance directions (positive/negative/flat) disclosed. Critical details such as agreement terms, financial impacts, and quantitative data are NOT_DISCLOSED.

10-02-2026

CTS Corp filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits (filing size 11 MB). This multi-item filing provides material non-public information via attached exhibits to comply with Regulation FD. No specific financial metrics, transactions, or performance data are disclosed in the provided filing information.

10-02-2026

Fifth Third Bancorp filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material non-public information with attached exhibits. No quantitative financial metrics, transaction details, or performance comparisons are disclosed in the filing summary.

10-02-2026

Genprex, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or material transactions are mentioned.

10-02-2026

Nektar Therapeutics filed an 8-K on February 10, 2026, under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific core events, transactions, financial metrics, or quantitative details are disclosed in the provided filing summary. This is a multi-item filing with no mentioned positive or negative performance indicators.

10-02-2026

GCM Grosvenor Inc. filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are disclosed in the provided summary. No quantitative metrics, positive or negative changes, or flat performance indicators are mentioned.

10-02-2026

Invesco Ltd. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure, indicating a voluntary release of material nonpublic information, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing complies with Reg FD safe harbor but provides no specific details on the disclosed information, transactions, financial metrics, or impacts. No quantitative data, positive or negative metrics, or period-over-period comparisons are mentioned.

10-02-2026

Ecolab Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, indicating potential restructuring expenses. Financial statements and exhibits are provided under Item 9.01. No specific revenue, earnings, costs, guidance, or period-over-period metrics are disclosed.

10-02-2026

Open Text Corp filed a Form 8-K on February 10, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative impacts.

• ·Multi-item 8-K filing (Items 8.01 and 9.01)
• ·AccNo: 0001002638-26-000024

10-02-2026

Evommune, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-043771), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with a file size of 13 MB, indicating potential attachments such as press releases or presentations, but no specific details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided summary. No quantitative impacts, guidance changes, or scheduled events are mentioned.

10-02-2026

Aardvark Therapeutics, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the filing summary. No quantitative financial metrics, transactions, or performance comparisons (positive, negative, or flat) are mentioned.

10-02-2026

Cencora, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001140859-26-000012, Size: 10 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item filing with potentially significant attachments given the file size.

10-02-2026

Oxbridge Re Holdings Ltd filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure, indicating a voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits, which attaches supporting documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. This appears to be an informational filing without directional financial impact.

10-02-2026

RGC Resources Inc filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core events, transactions, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

10-02-2026

IRADIMED CORP filed a Form 8-K on 2026-02-10 under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, balance sheet impacts, guidance, period-over-period changes, or other quantitative metrics are provided in the filing summary. This is an informational earnings-related disclosure without detailed financial data.

10-02-2026

EQV Ventures Acquisition Corp. filed an 8-K on 2026-02-10 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, or performance comparisons are explicitly stated in the provided filing information. Sector is not specified.

10-02-2026

RXO, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure of potentially material non-public information with attached exhibits, but no specific details, metrics, positives, negatives, or flat performance indicators are provided in the summary. No quantitative financial or operational data is available.

10-02-2026

Galecto, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-043741), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), amendments to articles of incorporation or bylaws or fiscal year change under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details on positions affected, reasons for changes, board impacts, or quantitative data are NOT_DISCLOSED. No positive or negative metrics reported.

• ·Filing size: 290 KB

10-02-2026

Shift4 Payments, Inc. filed an 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 references financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are disclosed.

10-02-2026

SCI Engineered Materials, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012363, Size: 168 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the exhibits are disclosed in the provided filing summary. No financial metrics, transactions, or directional impacts are mentioned.

10-02-2026

TruGolf Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details of the event, transaction values, financial metrics, or impacts are disclosed in the provided filing information. This is a single-item filing with no quantitative data or named entities beyond the company itself.

10-02-2026

SAFE & GREEN HOLDINGS CORP. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics were disclosed.

10-02-2026

Mount Logan Capital Inc. filed an 8-K on February 10, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, or any quantitative impacts are NOT_DISCLOSED.

10-02-2026

AtlasClear Holdings, Inc. filed a multi-item Form 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, unregistered sales of equity securities under Item 3.02, and other events under Item 8.01, with exhibits listed under Item 9.01. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are provided in the filing summary. No positive or negative metrics are disclosed.

10-02-2026

Hillenbrand, Inc. disclosed in its 8-K filing the entry into a new material definitive agreement (Item 1.01) and termination of a prior material definitive agreement (Item 1.02), alongside completion of an acquisition or disposition of assets (Item 2.01). The filing also reports creation of direct financial obligations (Item 2.03), notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to security holder rights (Item 3.03), changes in control of the registrant (Item 5.01), and changes in directors/officers including compensatory arrangements (Item 5.02), with partial mention of amendments to articles of incorporation (Item 5.03). No quantitative financial terms, parties involved, or specific impacts are disclosed.

10-02-2026

Eva Live Inc filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of any exhibits are disclosed in the filing summary. This is a multi-item filing with limited information provided.

10-02-2026

Prudential Financial Inc filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons for change, appointment or resignation status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

10-02-2026

Transocean Ltd. filed an 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, transaction details, financial impacts, period-over-period comparisons, or positive/negative performance indicators are disclosed. This is a multi-item filing with no specified dollar values, strategic context, or market implications provided.

10-02-2026

NextTrip, Inc. filed an 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure, financial statements, exhibits, transactions, metrics, or events are provided. This is a multi-item voluntary filing with no disclosed quantitative impacts.

10-02-2026

Paramount Skydance Corp filed a Form 8-K on February 10, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with attached exhibits.

10-02-2026

Reliance Global Group, Inc. filed a Form 8-K on 2026-02-10 reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, accompanied by Regulation FD disclosure (Item 7.01) and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed. No positive or negative metrics provided, resulting in purely informational disclosure.

10-02-2026

Agassi Sports Entertainment Corp. filed a Form 8-K on February 10, 2026, under Item 7.01 Regulation FD Disclosure, indicating the release of material nonpublic information to the public, and Item 9.01 Financial Statements and Exhibits, suggesting attachments such as press releases or presentations. No specific details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided filing information.

10-02-2026

J M Smucker Co filed an 8-K on February 10, 2026 (AccNo: 0000091419-26-000007, Size: 192 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the affected officer, position (e.g., CEO, CFO), reason for change (e.g., resignation, retirement, appointment), timing, or internal/external nature are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

• ·AccNo: 0000091419-26-000007
• ·File Size: 192 KB
• ·Sector: not specified

10-02-2026

ELECTRONIC ARTS INC. filed a Form 8-K on February 10, 2026 (AccNo: 0001140361-26-004514, size: 162 KB), reporting solely under Item 8.01 Other Events. No details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed. This appears to be a single-item, likely voluntary disclosure with no quantitative data provided.

10-02-2026

Valaris Ltd filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement's nature, parties, value, financial impacts, or other metrics were disclosed.

10-02-2026

Amentum Holdings, Inc. filed an 8-K on February 10, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details on proposals, vote outcomes, numerical results, or other metrics are disclosed.

10-02-2026

BioCardia, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.

10-02-2026

iPower Inc. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing focused on a material transaction and additional disclosures. No specific transaction details, financial metrics, dollar values, or performance changes (positive, negative, or flat) were disclosed.

10-02-2026

YORK WATER CO filed an 8-K on 2026-02-10 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are disclosed. No quantitative data, financial metrics, or scheduled events are mentioned.

10-02-2026

ADDENTAX GROUP CORP. filed an 8-K on February 10, 2026, under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the reported events, transactions, financial metrics, or exhibits are disclosed in the provided filing information. No quantitative data, positive or negative metrics, or performance comparisons are mentioned.

10-02-2026

Zillow Group, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001617640-26-000012, Size: 5 MB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing disclosing financial results, but no specific revenue, earnings, guidance, or quantitative metrics are mentioned in the provided filing details. No positive, negative, or flat performance indicators are disclosed.

10-02-2026

Essential Utilities, Inc. filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transactions, period-over-period comparisons, or other quantitative data were disclosed in the filing summary provided. No positive or negative performance indicators mentioned.

10-02-2026

McDonald's Corp filed an 8-K on February 10, 2026 (AccNo: 0000063908-26-000028, Size: 155 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons, or timing are disclosed.

10-02-2026

American Water Works Company, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001410636-26-000024, Size: 158 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, guidance, or operational updates are explicitly stated in the provided filing information. This appears to be a single-item, voluntary disclosure intended to comply with SEC Regulation Fair Disclosure requirements.

10-02-2026

LEE ENTERPRISES, Inc filed an 8-K on February 10, 2026, under Item 9.01: Financial Statements and Exhibits. No specific financial statements, exhibits, transactions, metrics, or events are detailed in the filing summary provided. No positive or negative performance indicators are disclosed.

10-02-2026

FIRST MERCHANTS CORP filed a Form 8-K on February 10, 2026 (AccNo: 0000712534-26-000019, Size: 194 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other events, transaction values, financial metrics, or exhibits are disclosed in the filing summary. Critical event content and quantitative data are missing.

10-02-2026

NORTHERN TRUST CORP filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transactions, guidance, or other quantitative details are disclosed in the filing summary. This appears to be a voluntary disclosure with attached exhibits of unknown content.

10-02-2026

Univest Financial Corp filed an 8-K on February 10, 2026, under Item 8.01 Other Events. No specific details on the core event, financial metrics, transactions, or impacts are disclosed. No quantitative data, period-over-period comparisons, or scheduled events mentioned.

10-02-2026

UWHARRIE CAPITAL CORP filed an 8-K on February 10, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or quantitative financial metrics were disclosed in the provided filing details. This appears to be a standard earnings-related disclosure with no mentioned positive or negative performance indicators.

10-02-2026

Farmers National Banc Corp /OH/ filed a Form 8-K on February 10, 2026, disclosing under Item 5.03 amendments to Articles of Incorporation or Bylaws or a change in Fiscal Year, under Item 5.07 submission of matters to a vote of security holders, under Item 7.01 Regulation FD Disclosure, and under Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transaction values, vote outcomes, amendment descriptions, or quantitative impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial implications evident.

10-02-2026

StoneBridge Acquisition II Corp filed an 8-K on February 10, 2026 (AccNo: 0001829126-26-001192) under Item 8.01 Other Events announcing a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or impacts are disclosed in the provided filing summary. Sector is not specified, and no quantitative metrics, positive or negative changes, or scheduled events are mentioned.

10-02-2026

AMERICAN EXPRESS CO filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transactions, financial metrics, or exhibits are provided in the filing summary. No positive, negative, or flat metrics are mentioned.

10-02-2026

Marygold Companies, Inc. filed an 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. This is an informational disclosure of results without quantified metrics.

10-02-2026

Ford Motor Co filed an 8-K on February 10, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition. Item 9.01 includes Financial Statements and Exhibits. No specific financial metrics, transaction details, or performance data are disclosed.

10-02-2026

MasterBrand, Inc. filed an 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific financial metrics, performance comparisons, or guidance details are NOT_DISCLOSED. No positive or negative metrics are explicitly stated in the provided filing information.

10-02-2026

INNOVATE Corp. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing summary. No quantitative metrics, comparisons, or directional changes are mentioned.

10-02-2026

Manitowoc Co Inc filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure, which typically involves voluntary release of material non-public information, and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or performance data are disclosed in the filing summary. All quantitative impacts and directional changes remain NOT_DISCLOSED.

10-02-2026

Lattice Semiconductor Corp filed a Form 8-K on 2026-02-10 under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. Sector is not specified.

10-02-2026

W. P. Carey Inc. filed an 8-K on 2026-02-10 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing information. No positive, negative, or flat performance indicators are detailed.

10-02-2026

UMB Financial Corp filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions, reasons for change, or quantitative data were disclosed.

• ·AccNo: 0001193125-26-044638
• ·File Size: 200 KB
• ·Sector: not specified

10-02-2026

Angi Inc. filed a Form 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive, negative, or flat performance indicators are available.

10-02-2026

Exelixis, Inc. filed an 8-K on February 10, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. No positive, negative, or flat metrics are mentioned.

10-02-2026

Office Properties Income Trust filed an 8-K on February 10, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with voluntary disclosure under Regulation FD, attaching unspecified financial statements and exhibits. No specific financial metrics, transactions, guidance, or performance data—positive, negative, or flat—are disclosed.

10-02-2026

Rambus Inc filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

10-02-2026

Rapid7, Inc. filed an 8-K on 2026-02-10 (AccNo: 0001560327-26-000004) under Item 2.02 for results of operations and financial condition, Item 5.02 for departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, and Item 9.01 for financial statements and exhibits. No specific details on the leadership change, including key position, appointment or resignation status, reasons, or timing, are disclosed. No quantitative financial metrics, period-over-period comparisons, or other numerical data are provided.

10-02-2026

InvenTrust Properties Corp. filed an 8-K on February 10, 2026, under Item 2.02 announcing Results of Operations and Financial Condition. Item 9.01 includes Financial Statements and Exhibits. No specific financial metrics, period-over-period changes, or other quantitative data disclosed in the filing summary.

10-02-2026

Genasys Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044673, Size: 419 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing reporting financial results, but specific revenue, earnings, balance sheet details, guidance, or period-over-period comparisons are NOT_DISCLOSED in the provided filing information. No positive, negative, or flat performance metrics are available for analysis.

10-02-2026

MNTN, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001891027-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results with all key figures NOT_DISCLOSED.

10-02-2026

Varex Imaging Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001681622-26-000015), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is an informational disclosure of financial results with attached exhibits.

10-02-2026

BlackLine, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or directional changes (positive, negative, or flat) are disclosed in the filing summary. This appears to be a standard earnings-related disclosure without quantified details provided.

10-02-2026

Willis Lease Finance Corp filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. Content of the disclosure and exhibits is NOT_DISCLOSED.

10-02-2026

Klaviyo, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, balance sheet details, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings release attachment.

• ·AccNo: 0001835830-26-000005
• ·Filing size: 515 KB
• ·Sector: not specified

10-02-2026

iBio, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001420720-26-000003), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. Sector is not specified.

10-02-2026

Permian Basin Royalty Trust filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This is a multi-item informational filing with no directional financial data available.

10-02-2026

NMI Holdings, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 announcing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard earnings-related disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing summary.

10-02-2026

Welltower Inc. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative data are disclosed in the provided filing description. This represents a standard mandatory disclosure for financial results.

10-02-2026

Agree Realty Corp filed an 8-K on February 10, 2026 (AccNo: 0000917251-26-000012, Size: 11 MB), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing disclosing financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are explicitly stated in the provided filing details.

10-02-2026

Lyft, Inc. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), indicating a standard earnings-related disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing details. Critical financial data such as period-over-period changes remains NOT_DISCLOSED.

10-02-2026

Exact Sciences Corp filed an 8-K on February 10, 2026, under Item 8.01 Other Events, indicating a material event deemed important by the company. No specific details on the core event, financial impacts, or quantitative metrics are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative metrics.

10-02-2026

Boston Beer Co Inc filed an 8-K on February 10, 2026, under Item 5.02 disclosing a matter related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative data are disclosed.

10-02-2026

Robinhood Markets, Inc. filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition under Item 2.02, and financial statements and exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, internal/external status, and timing are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

10-02-2026

La Rosa Holdings Corp. filed an 8-K on 2026-02-10 (AccNo: 0001213900-26-014257) disclosing under Item 1.01 its entry into a material definitive agreement and under Item 2.01 the completion of an acquisition or disposition of assets. Item 9.01 provides financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial impacts were disclosed.

10-02-2026

Astera Labs, Inc. filed an 8-K on February 10, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits attached under Item 9.01. No specific transaction details, financial metrics, dollar values, or impacts are disclosed in the provided filing summary.

10-02-2026

Upstart Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting Results of Operations and Financial Condition under Item 2.02 and including Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a standard earnings-related disclosure without quantitative details available for analysis.

10-02-2026

Claros Mortgage Trust, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044627), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any financial impacts are disclosed. This appears to be a routine governance disclosure without quantified metrics or directional implications.

10-02-2026

byNordic Acquisition Corp filed an 8-K on 2026-02-10 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), potentially related to a merger or acquisition announcement. No specific details on parties, structure, valuation, or financial metrics are disclosed in the provided filing information. File size is 259 KB with AccNo 0001213900-26-014250; sector not specified.

10-02-2026

AMERICAN INTERNATIONAL GROUP, INC. filed an 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information.

10-02-2026

Spectral AI, Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, appointment or resignation status, reasons for change, timing, board impacts, or quantitative metrics are disclosed in the provided filing information. Critical leadership change elements remain NOT_DISCLOSED, limiting assessment of governance or market implications.

10-02-2026

Monte Rosa Therapeutics, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044616), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative data are disclosed. This appears to be a routine disclosure of leadership or governance changes with no additional context provided.

10-02-2026

10-02-2026

Sun Communities Inc filed a Form 8-K on February 10, 2026 (AccNo: 0000912593-26-000060), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, effective dates, or any quantitative terms are disclosed.

10-02-2026

Constellation Energy Corp filed an 8-K on February 10, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, effective date, or any quantitative impacts are disclosed.

10-02-2026

Red Rock Resorts, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-044612), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results with no specific revenue, earnings, or other quantitative metrics provided in the filing description. No positive or negative performance indicators, period-over-period changes, or guidance were detailed.

10-02-2026

Energy Fuels Inc filed an 8-K on February 10, 2026, disclosing under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific transaction values, financial metrics, dollar amounts, share counts, or period-over-period changes are disclosed in the provided filing summary. This is a multi-item filing likely related to a financing transaction, but lacks quantitative details for impact assessment.

10-02-2026

AMCON DISTRIBUTING CO filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the events, transactions, financial metrics, or exhibits are provided in the filing summary. All quantitative data, impacts, and strategic context are NOT_DISCLOSED.

10-02-2026

21Shares Ethereum ETF filed an 8-K on 2026-02-10 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details, financial metrics, transaction values, parties, or impacts are provided in the filing summary.

10-02-2026

PMGC Holdings Inc. filed an 8-K on 2026-02-10 disclosing entry into a Material Definitive Agreement under Item 1.01. The filing also reports Financial Statements and Exhibits under Item 9.01. No specific details on the agreement terms, parties, financial impacts, or metrics are disclosed.

10-02-2026

Becton Dickinson & Co filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits disclosed in the provided filing summary. No positive or negative metrics, numerical values, or strategic impacts are mentioned.

10-02-2026

Mirion Technologies, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. No period-over-period comparisons, guidance, or performance details (positive, negative, or flat) are mentioned.

10-02-2026

Advanced Energy Industries Inc filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard voluntary disclosure of quarterly or annual financial results.

10-02-2026

Build-A-Bear Workshop Inc filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with additional other events under Item 8.01 and financial statements/exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any timing or succession information are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are provided in the filing summary.

10-02-2026

NETSTREIT Corp. filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006843), disclosing Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are disclosed in the provided information. No positive or negative metrics are available for balanced assessment.

10-02-2026

Cloudflare, Inc. filed an 8-K on February 10, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on the affected officer, position, reason for change, timing, or any quantitative impacts are disclosed.

10-02-2026

21Shares Solana ETF filed an 8-K on 2026-02-10 under Item 1.01 reporting entry into a Material Definitive Agreement and under Item 9.01 providing Financial Statements and Exhibits. No specific details on the agreement, transaction size, financial impacts, or other metrics are disclosed. This is a multi-item filing with no quantitative data provided.

10-02-2026

Sonim Technologies Inc filed an 8-K on February 10, 2026 (AccNo: 0001493152-26-005966) disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on personnel involved, positions affected, reasons for changes, timing, or terms are disclosed.

10-02-2026

Jackson Acquisition Co II filed an 8-K on February 10, 2026, under Item 3.01 disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing, which signals potential liquidity and compliance risks with no further details provided. Item 9.01 includes financial statements and exhibits, but no quantitative metrics, deal specifics, or positive developments are mentioned. No positive or flat metrics are disclosed to offset the negative listing notice.

10-02-2026

Insteel Industries Inc. filed an 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, financial statements, exhibits, transaction values, or quantitative metrics were disclosed in the filing summary. This is a multi-item voluntary disclosure with no mentioned positive or negative performance metrics.

10-02-2026

Hercules Capital, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the core transaction, dollar values, terms, or financial impacts disclosed in the provided information. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

10-02-2026

Mattel Inc. /DE/ filed an 8-K on February 10, 2026 (AccNo: 0001628280-26-006840, Size: 813 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific revenue, earnings, guidance, or other metrics are mentioned; all quantitative details are NOT_DISCLOSED.

10-02-2026

Adient plc filed an 8-K on February 10, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing summary. This is a multi-item voluntary disclosure with no quantified impacts mentioned.

10-02-2026

Freshworks Inc. filed an 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition. No specific financial metrics, revenue, earnings, guidance, comparisons, or other quantitative details are provided in the filing information. Additional impacts, events, or data such as balance sheet effects or outlook revisions are NOT_DISCLOSED.

10-02-2026

National Bank Holdings Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001475841-26-000006, Size: 9 MB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, but specific details of the disclosure, financial metrics, transactions, or events are NOT_DISCLOSED.

10-02-2026

Acadia Realty Trust filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044722), reporting Results of Operations and Financial Condition under Item 2.02 and attaching Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, revenue, earnings, balance sheet details, guidance, or period-over-period comparisons were explicitly stated in the provided filing information. This is a standard earnings-related disclosure with no directional performance data available.

• ·Filing size: 12 MB, indicating potential detailed exhibits
• ·Event Type: Financial Results
• ·Source: us_sec

10-02-2026

CNB Financial Corp/PA filed an 8-K on February 10, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or the nature of the financial statements and exhibits are disclosed in the filing summary. No quantitative metrics, transactions, or directional impacts are provided.

10-02-2026

Electromed, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001437749-26-003636), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results, but no specific revenue, earnings, margins, or other metrics are provided. No period-over-period comparisons, positive or negative performance indicators, or guidance changes are mentioned.

10-02-2026

INTERNATIONAL BATTERY METALS LTD. filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results alongside unregistered equity securities sales, but no specific revenue, earnings, transaction values, or quantitative metrics are provided in the filing description. No positive or negative performance indicators, period-over-period comparisons, or guidance changes are mentioned.

10-02-2026

Pegasystems Inc filed an 8-K on February 10, 2026, under Item 2.02 disclosing results of operations and financial condition, Item 8.01 for other events, and Item 9.01 attaching financial statements and exhibits. No specific revenue, earnings, guidance, or other financial metrics are detailed in the provided filing information. This is a standard earnings-related disclosure with no quantified positive or negative performance indicators available.

10-02-2026

Fermi Inc. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific transaction details, dollar values, parties involved, financial metrics, or impacts are disclosed.

10-02-2026

Capital Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001419536-26-000012), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. Item 9.01 notes financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or quantitative impacts are disclosed.

• ·Event Type: Officer Change
• ·Source: us_sec
• ·File Size: 4 MB

10-02-2026

Northern Oil & Gas, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are disclosed in the provided filing description. No positive or negative metrics are available for balanced assessment.

10-02-2026

EGH Acquisition Corp. filed an 8-K on 2026-02-10 (AccNo: 0001104659-26-012621, Size: 401 KB) disclosing information under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on merger/acquisition structure, parties, valuation, financial metrics, or performance comparisons are provided in the filing summary. All quantitative data, named parties beyond the filer, and transaction terms are NOT_DISCLOSED.

10-02-2026

Douglas Emmett Inc filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided information. This is a standard earnings-related voluntary disclosure with a filing size of 12 MB.

10-02-2026

Exicure, Inc. filed an 8-K on February 10, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative data were provided in the filing summary. No positive or negative governance implications, board composition changes, or market impacts can be assessed due to lack of disclosed information.

10-02-2026

BiomX Inc. filed an 8-K on February 10, 2026, reporting the completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements under Item 5.02. Financial statements and exhibits are included under Item 9.01, with no specific transaction details, parties, values, or metrics disclosed.

10-02-2026

Marwynn Holdings, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001213900-26-014297, Size: 231 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the nature of the other events, financial statements, or exhibits provided. No quantitative metrics, transactions, or performance data are disclosed.

• ·Filing date: 2026-02-10
• ·Sector: NOT_DISCLOSED

10-02-2026

Edwards Lifesciences Corp filed an 8-K on February 10, 2026, reporting under Item 2.02 Results of Operations and Financial Condition, with Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified performance data.

10-02-2026

Ivanhoe Electric Inc. filed a Form 8-K on 2026-02-10 under Item 1.01 disclosing entry into a material definitive agreement. Item 9.01 reports financial statements and exhibits. No details on the agreement terms, transaction value, financial impacts, or other metrics are disclosed.

10-02-2026

Danaher Corp /DE/ filed an 8-K on February 10, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative terms such as compensation amounts are disclosed.

10-02-2026

Assurant, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001267238-26-000006), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits) to disclose financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are mentioned in the provided filing information. No positive, negative, or flat performance indicators are disclosed.

10-02-2026

Southwest Airlines Co filed an 8-K on February 10, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, or financial implications were provided in the filing summary. No quantitative metrics, performance comparisons, or scheduled events mentioned.

• ·Filing accession number: 0001193125-26-044746
• ·Filing size: 159 KB
• ·Sector: not specified

10-02-2026

Artisan Partners Asset Management Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the other events or exhibits disclosed in the provided information. No financial metrics, positive or negative changes, or impacts are mentioned.

10-02-2026

Five Point Holdings, LLC filed an 8-K on February 10, 2026, disclosing unregistered sales of equity securities under Item 3.02 and other events under Item 8.01. Item 9.01 lists financial statements and exhibits. No quantitative details such as transaction values, share counts, financial metrics, or period-over-period comparisons are provided.

10-02-2026

NextEra Energy Inc filed a Form 8-K on February 10, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing, but specific details of the other events, transactions, financial statements, or exhibits are NOT_DISCLOSED. No quantitative metrics, changes, or directional impacts are provided in the filing summary.

10-02-2026

Diversified Energy Co filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No specific transaction details, dollar values, strategic impacts, or financial metrics are disclosed.

10-02-2026

Unity Software Inc. filed an 8-K on February 10, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, timing, governance implications, or any quantitative metrics are explicitly stated. No positive or negative performance metrics, scheduled events, or financial impacts are mentioned.

10-02-2026

Evolution Petroleum Corp filed an 8-K on February 10, 2026 (AccNo: 0001104659-26-012681), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, guidance, or other quantitative metrics are NOT_DISCLOSED in the provided filing description. No period-over-period comparisons, transaction details, or scheduled events are mentioned.

10-02-2026

German American Bancorp, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the core event, financial metrics, transactions, or other quantitative data are disclosed in the provided filing summary. The filing has AccNo: 0000714395-26-000007 and size of 3 MB.

10-02-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on February 10, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the officer involved, position affected, reason for change, timing, financial metrics, or other quantitative data are disclosed.

• ·Filing Accession Number: 0000947871-26-000107
• ·Filing Size: 229 KB

10-02-2026

10-02-2026

Greenwave Technology Solutions, Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any related compensation arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

10-02-2026

Weis Markets Inc. filed an 8-K on February 10, 2026 (AccNo: 0000105418-26-000003, Size: 383 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including the officer's name, title, reason for change, appointment or resignation status, and any financial metrics are NOT_DISCLOSED.

• ·Filing date: 2026-02-10
• ·AccNo: 0000105418-26-000003
• ·File size: 383 KB
• ·Sector: not specified

10-02-2026

O-I Glass, Inc. /DE/ filed a Form 8-K on February 10, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. This is an informational filing with no quantitative metrics available for analysis.

10-02-2026

AMERICAN REBEL HOLDINGS INC filed an 8-K on February 10, 2026, under Item 3.01 disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing. Item 3.02 reports unregistered sales of equity securities, and Item 9.01 includes financial statements and exhibits. No quantitative financial metrics, transaction values, or period-over-period comparisons were disclosed.

10-02-2026

Rhinebeck Bancorp, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001104659-26-012668), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. No quantitative data, period-over-period comparisons, positive or negative metrics, or strategic implications are mentioned.

10-02-2026

Insparity, Inc. filed a Form 8-K on February 10, 2026, reporting results of operations and financial condition under Item 2.02 alongside costs associated with exit or disposal activities under Item 2.05, suggesting potential restructuring charges impacting financials. Item 9.01 provides financial statements and exhibits. Specific revenue, earnings, cost amounts, or period-over-period metrics are NOT_DISCLOSED.

10-02-2026

NBT Bancorp Inc filed an 8-K on February 10, 2026 (AccNo: 0001140361-26-004620, Size: 148 KB) reporting Item 7.01 Regulation FD Disclosure. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.

10-02-2026

IEH Corp filed a Form 8-K on February 10, 2026 (AccNo: 0001174947-26-000154), disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data were explicitly stated in the filing description. Sector not specified, representing a standard earnings-related disclosure without detailed performance metrics.

10-02-2026

QuantumScape Corp filed an 8-K on 2026-02-10 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, whether it is an appointment or resignation, reasons for the change, or any quantitative impacts are provided in the filing summary. No positive or negative metrics, financial data, or governance implications are disclosed.

• ·AccNo: 0001193125-26-044778
• ·Filing size: 145 KB
• ·Event date: 2026-02-10

10-02-2026

LSB Industries, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044775), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, timing, or compensatory arrangements are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

10-02-2026

CHINA PHARMA HOLDINGS, INC. filed a Form 8-K on February 10, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with exhibits under Item 9.01. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

10-02-2026

Coursera, Inc. filed a Form 8-K on February 10, 2026 (AccNo: 0001651562-26-000008), reporting under Item 8.01 Other Events. No specific details on the core event, financial metrics, transactions, or impacts are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure with no quantitative data available.

10-02-2026

Oportun Financial Corp filed a Form 8-K on February 10, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. The filing is multi-item, also including Item 8.01 for other events and Item 9.01 for financial statements and exhibits. No specific transaction details, dollar values, terms, or quantitative impacts are disclosed.

10-02-2026

Iris Acquisition Corp II filed an 8-K on February 10, 2026 (AccNo: 0001185185-26-000487, Size: 423 KB), disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01 in connection with a merger/acquisition event. No specific deal structure, parties involved, valuation, financial terms, synergies, regulatory details, or shareholder impacts are disclosed. Sector is not specified, and no quantitative metrics or comparisons are provided.

10-02-2026

VAALCO Energy Inc. filed a Form 8-K on February 10, 2026 (event date same as filing date), reporting under Item 1.01 entry into a material definitive agreement, Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing combining a significant transaction announcement with financial updates. No specific transaction details, financial metrics, period-over-period comparisons, dollar values, or performance directions (positive, negative, or flat) are disclosed in the provided information.

• ·AccNo: 0000894627-26-000005; Filing size: 21 MB (suggests detailed exhibits)
• ·Critical missing information: Filing content, agreement terms, financial metrics/revenue/earnings, balance sheet effects, guidance, dollar values, YoY/QoQ changes, scheduled events (e.g., earnings calls), named counterparties/executives, sector context - limits analysis quality to low confidence

10-02-2026

FLYEXCLUSIVE INC. filed a Form 8-K on 2026-02-10 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no quantitative metrics, transaction details, parties, financial impacts, or performance comparisons provided in the summary. No positive or negative metrics are disclosed.

• ·Filing accession number: 0001193125-26-044827
• ·Filing size: 961 KB
• ·Sector: NOT_DISCLOSED

10-02-2026

Udemy, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events. No details on the specific nature of the event, financial impacts, quantitative metrics, or comparisons are disclosed. No positive or negative metrics are mentioned.

10-02-2026

UNITED STATES ANTIMONY CORP filed an 8-K on February 10, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the filing summary. This appears to be a voluntary disclosure with attached exhibits, but content details are not provided.

10-02-2026

UNITED RENTALS, INC. filed a Form 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the content of the disclosure, financial metrics, transactions, or operational updates are provided in the filing summary. This is an informational filing with no quantified positive or negative impacts disclosed.

10-02-2026

Pineapple Financial Inc. filed an 8-K on 2026-02-10 disclosing an officer change under Item 5.02, covering potential departures of directors or certain officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

10-02-2026

Praxis Precision Medicines, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001689548-26-000016, Size: 195 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. Specific details including the affected officer, position (e.g., CEO, CFO), appointment or resignation status, reasons, timing, and any compensation are NOT_DISCLOSED.

10-02-2026

COVENANT LOGISTICS GROUP, INC. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial impacts, transactions, or metrics are disclosed in the filing summary. Critical content of the events and any attached exhibits is missing, limiting assessment of materiality.

10-02-2026

GXO Logistics, Inc. filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information.

10-02-2026

DIODES INC /DEL/ filed a Form 8-K on February 10, 2026 (AccNo: 0001193125-26-044898), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but specific metrics such as revenue, earnings, guidance, or period-over-period changes are NOT_DISCLOSED. No positive or negative performance indicators, transaction details, or scheduled events are mentioned.

10-02-2026

Centrus Energy Corp filed an 8-K on February 10, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with all quantitative details NOT_DISCLOSED.

• ·Filing Accession Number: 0001628280-26-006909
• ·Filing Size: 492 KB
• ·Event Type: Financial Results
• ·Sector: NOT_DISCLOSED

10-02-2026

MAINZ BIOMED N.V. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events, which covers material events not specified in other items. Item 9.01 discloses Financial Statements and Exhibits, but specific details of the events or exhibits are NOT_DISCLOSED. No financial metrics, transactions, or directional impacts are provided.

10-02-2026

Black Stone Minerals, L.P. filed an 8-K on February 10, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details including key positions affected, names, reasons for change, or impacts are NOT_DISCLOSED.

10-02-2026

VisionWave Holdings, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the filing summary provided.

10-02-2026

FARADAY FUTURE INTELLIGENT ELECTRIC INC. filed an 8-K on February 10, 2026 (AccNo: 0001213900-26-014347), reporting under Item 1.01 entry into a material definitive agreement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details, dollar values, financial metrics, positive or negative changes, or period-over-period comparisons are disclosed in the provided filing summary. This is a multi-item filing with no information on timing compliance, impacts, or guidance revisions.

10-02-2026

MEXCO ENERGY CORP filed an 8-K on February 10, 2026 (AccNo: 0001493152-26-005985, Size: 213 KB) under Item 2.02 for Results of Operations and Financial Condition, Item 8.01 for Other Events, and Item 9.01 for Financial Statements and Exhibits. This multi-item filing discloses financial results as an Event Type: Financial Results from the US market. No specific revenue, earnings, balance sheet effects, guidance, or quantitative metrics are disclosed.

10-02-2026

reAlpha Tech Corp. filed an 8-K on 2026-02-10 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing, which is a highly material negative event. Item 5.02 discloses departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers, potentially indicating management instability. No quantitative financial metrics, specific names, dollar values, or further details provided.

10-02-2026

Sadot Group Inc. filed a Form 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.02 unregistered sales of equity securities, and Item 9.01 financial statements and exhibits. This multi-item filing signals significant corporate developments such as a key contract or financing arrangement potentially involving equity issuance. No quantitative details, financial impacts, dollar values, share counts, or performance metrics (positive, negative, or flat) are disclosed.

10-02-2026

Neuronetics, Inc. filed a Form 8-K on February 10, 2026, under Item 2.02 to disclose results of operations and financial condition as part of its financial results announcement. Item 9.01 provides financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing details.

10-02-2026

Sutro Biopharma, Inc. filed a Form 8-K on 2026-02-10 reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details regarding the agreement, transaction terms, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing under SEC rules, but timing compliance and core event details are NOT_DISCLOSED.

10-02-2026

Franklin BSP Realty Trust, Inc. filed a Form 8-K on 2026-02-10 disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 9.01 for financial statements and exhibits. No specific details on the officer(s) involved, position affected, reason for change, or any quantitative impacts are disclosed.

10-02-2026

UPEXI, INC. filed an 8-K on February 10, 2026, furnishing Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results and other events with attached exhibits. No specific revenue, earnings, or other quantitative financial metrics are disclosed.

10-02-2026

MGT Capital Investments, Inc. filed a Form 8-K on 2026-02-10 disclosing entry into a material definitive agreement (Item 1.01) and unregistered sales of equity securities (Item 3.02), a multi-item mandatory filing with exhibits under Item 9.01. No quantitative details such as transaction values, share counts, or financial impacts are provided. This informational disclosure lacks specifics on positive or negative effects.

• ·AccNo: 0001493152-26-006008
• ·File size: 195 KB
• ·Sector: NOT_DISCLOSED

10-02-2026

bioAffinity Technologies, Inc. filed an 8-K on February 10, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosed information, financial metrics, transactions, or exhibits are provided in the filing description. No quantitative data, performance metrics, or directional changes are mentioned.

10-02-2026

Atmos Energy Corp filed a Form 8-K on February 10, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, under Item 5.07 the submission of matters to a vote of security holders (likely annual meeting results), and under Item 9.01 financial statements and exhibits. This is a multi-item, mandatory disclosure typical post-shareholder meeting with no specific details on amendment content, vote outcomes, or financial metrics provided. No positive or negative metrics are disclosed, resulting in purely informational impact.

10-02-2026

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed an 8-K on February 10, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the other event, transaction values, financial metrics, or exhibits are provided in the filing summary. No positive, negative, or flat performance metrics are mentioned.

10-02-2026

Paycom Software, Inc. filed an 8-K on February 10, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events or the nature of the exhibits are disclosed. This filing provides no quantitative metrics, comparisons, or directional information.

10-02-2026

B. Riley Financial, Inc. filed a Form 8-K on February 10, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantified positive or negative impacts mentioned.

10-02-2026

Deluxe Corp filed an 8-K on February 10, 2026, reporting under Item 1.01 entry into a material definitive agreement. No specific details regarding the nature of the agreement, transaction value, parties involved, financial terms, or impacts are disclosed in the provided filing summary. This is a single-item mandatory disclosure with no quantitative metrics or comparisons provided.

10-02-2026

Celsius Holdings, Inc. filed an 8-K on February 10, 2026 (AccNo: 0001193125-26-044973), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative data are disclosed in the provided filing summary. No positive or negative metrics, financial impacts, or governance implications are mentioned.

10-02-2026

Hall Chadwick Acquisition Corp filed an 8-K on 2026-02-10 under Item 5.02, disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, financial details, transaction information, or quantitative metrics are mentioned in the filing details provided. No merger or acquisition is referenced in the disclosed Item.

10-02-2026

Cantor Equity Partners IV, Inc. filed an 8-K on February 10, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed. This appears to be a standard governance disclosure without additional context provided.